balance 1.5% glucose, 1.25 mmol/l calcium
fresenius medical care deutschland gmbh, nemecko - hypertonické roztoky - 87 - varia i
balance 4.25% glucose, 1.25 mmol/l calcium
fresenius medical care deutschland gmbh, nemecko - hypertonické roztoky - 87 - varia i
balance 2.3% glucose, 1.25 mmol/l calcium
fresenius medical care deutschland gmbh, nemecko - hypertonické roztoky - 87 - varia i
sorbisterit
fresenius medical care nephrologica deutschland gmbh, nemecko - polystyrénsulfonát - 87 - varia i
osvaren
fresenius medical care nephrologica deutschland gmbh, nemecko - kalciumacetát a magnéziumkarbonát - 39 - soli a ionty pro p.o. a parent. aplikÁciu
multibic 4 mmol/ l draslíka
fresenius medical care deutschland gmbh, nemecko - hemofiltráty - 87 - varia i
multibic 3 mmol/l draslíka
fresenius medical care deutschland gmbh, nemecko - hemofiltráty - 87 - varia i
multibic 2 mmol/l draslíka
fresenius medical care deutschland gmbh, nemecko - hemofiltráty - 87 - varia i
multibic bez draslíka
fresenius medical care deutschland gmbh, nemecko - hemofiltráty - 87 - varia i
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedémy, dedičné - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.